David E. Nichols

16.4k total citations · 4 hit papers
213 papers, 11.2k citations indexed

About

David E. Nichols is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Organic Chemistry. According to data from OpenAlex, David E. Nichols has authored 213 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Cellular and Molecular Neuroscience, 100 papers in Clinical Psychology and 83 papers in Organic Chemistry. Recurrent topics in David E. Nichols's work include Neurotransmitter Receptor Influence on Behavior (115 papers), Psychedelics and Drug Studies (100 papers) and Chemical synthesis and alkaloids (49 papers). David E. Nichols is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (115 papers), Psychedelics and Drug Studies (100 papers) and Chemical synthesis and alkaloids (49 papers). David E. Nichols collaborates with scholars based in United States, United Kingdom and Ireland. David E. Nichols's co-authors include Charles D. Nichols, Danuta Marona‐Lewicka, Richard B. Mailman, Andrew J. Hoffman, Michael P. Johnson, Jon E. Sprague, Robert Oberlender, G.K.W. Yim, Jason C. Parrish and David Nutt and has published in prestigious journals such as Nature, Cell and Chemical Reviews.

In The Last Decade

David E. Nichols

206 papers receiving 10.9k citations

Hit Papers

Psychedelics 2004 2026 2011 2018 2016 2004 2008 2020 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Psychedelics
    2016 1.1k citations David E. Nichols Pharmacological Reviews profile →
  2. Hallucinogens
    2004 876 citations David E. Nichols profile →
  3. Serotonin Receptors
    2008 675 citations David E. Nichols, Charles D. Nichols profile →
  4. Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
    2020 306 citations Kuglae Kim, Tao Che et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Nichols United States 53 6.5k 5.9k 3.5k 2.7k 2.1k 213 11.2k
Richard A. Glennon United States 57 7.3k 1.1× 3.7k 0.6× 3.1k 0.9× 6.3k 2.3× 2.5k 1.2× 343 13.6k
Matthias E. Liechti Switzerland 60 6.0k 0.9× 8.2k 1.4× 2.9k 0.8× 1.2k 0.4× 4.0k 1.9× 251 11.6k
Richard B. Rothman United States 70 12.6k 1.9× 2.3k 0.4× 1.4k 0.4× 8.9k 3.3× 2.7k 1.3× 387 17.5k
Franz X. Vollenweider Switzerland 66 7.2k 1.1× 9.0k 1.5× 3.9k 1.1× 1.3k 0.5× 1.5k 0.7× 152 14.1k
Kenner C. Rice United States 73 17.2k 2.6× 2.6k 0.4× 2.3k 0.7× 11.2k 4.2× 2.4k 1.1× 792 29.1k
Marius C. Hoener Switzerland 45 4.1k 0.6× 1.8k 0.3× 468 0.1× 3.0k 1.1× 1.5k 0.7× 94 6.7k
Jordi Riba Spain 47 2.4k 0.4× 4.7k 0.8× 1.8k 0.5× 548 0.2× 348 0.2× 92 6.4k
Adam L. Halberstadt United States 37 2.6k 0.4× 3.4k 0.6× 1.8k 0.5× 606 0.2× 525 0.2× 90 4.6k
David Erritzøe United Kingdom 45 4.7k 0.7× 7.1k 1.2× 3.9k 1.1× 797 0.3× 421 0.2× 140 9.7k
Glen B. Baker Canada 62 4.8k 0.7× 966 0.2× 573 0.2× 3.3k 1.3× 411 0.2× 430 13.6k

Countries citing papers authored by David E. Nichols

Since Specialization
Citations

This map shows the geographic impact of David E. Nichols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Nichols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Nichols more than expected).

Fields of papers citing papers by David E. Nichols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Nichols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Nichols. The network helps show where David E. Nichols may publish in the future.

Co-authorship network of co-authors of David E. Nichols

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Nichols. A scholar is included among the top collaborators of David E. Nichols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Nichols. David E. Nichols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Orla, David E. Nichols, Fatih Güleç, Joseph Perkins, & Edward Lester. (2025). A proposed novel combined milling and combustion performance model for fuel selection. Journal of the Energy Institute. 120. 102046–102046.
2.
Han, Jianming, Jingying Zhang, Sarah M. Bernhard, et al.. (2023). Ligand and G-protein selectivity in the κ-opioid receptor. Nature. 617(7960). 417–425. 43 indexed citations
3.
Hendricks, Peter S., Charles D. Nichols, Kathryn A. Cunningham, et al.. (2022). Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion. PubMed. 1(1). 2–11. 1 indexed citations
4.
Kim, Kuglae, Tao Che, Ouliana Panova, et al.. (2020). Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor. Cell. 182(6). 1574–1588.e19. 306 indexed citations breakdown →
5.
Nichols, David E.. (2016). Psychedelics. Pharmacological Reviews. 68(2). 264–355. 1128 indexed citations breakdown →
6.
Brandt, Simon D., Simon Elliott, Pierce V. Kavanagh, et al.. (2015). Analytical characterization of bioactive N ‐benzyl‐substituted phenethylamines and 5‐methoxytryptamines. Rapid Communications in Mass Spectrometry. 29(7). 573–584. 16 indexed citations
7.
Halberstadt, Adam L., David E. Nichols, & Mark A. Geyer. (2012). Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacology. 221(4). 709–718. 39 indexed citations
8.
Marona‐Lewicka, Danuta, Benjamin R. Chemel, & David E. Nichols. (2008). Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI. Psychopharmacology. 203(2). 265–277. 35 indexed citations
9.
Banks, Matthew L., Jon E. Sprague, David F. Kisor, et al.. (2007). Ambient Temperature Effects on 3,4-Methylenedioxymethamphetamine-Induced Thermodysregulation and Pharmacokinetics in Male Monkeys. Drug Metabolism and Disposition. 35(10). 1840–1845. 37 indexed citations
10.
Lewis, Mark H., Xuemei Huang, David E. Nichols, & Richard B. Mailman. (2006). D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinsons Disease. CNS & Neurological Disorders - Drug Targets. 5(3). 345–353. 31 indexed citations
11.
Chambers, James J., Deborah Kurrasch‐Orbaugh, & David E. Nichols. (2002). Translocation of the 5-alkoxy substituent of 2,5-dialkoxyarylalkylamines to the 6-position: effects on 5-HT2A/2C receptor affinity. Bioorganic & Medicinal Chemistry Letters. 12(15). 1997–1999. 19 indexed citations
12.
Nichols, David E., Jason D. Kilts, Cassandra Prioleau, et al.. (1999). Synthesis and Dopaminergic Properties of Benzo-Fused Analogues of Quinpirole and Quinelorane. Journal of Medicinal Chemistry. 42(5). 935–940. 11 indexed citations
13.
Marona‐Lewicka, Danuta & David E. Nichols. (1995). Complex stimulus properties of LSD: a drug discrimination study with α2-adrenoceptor agonists and antagonists. Psychopharmacology. 120(4). 384–391. 19 indexed citations
14.
Marona‐Lewicka, Danuta, Gyu‐Seek Rhee, Jon E. Sprague, & David E. Nichols. (1995). Psychostimulant-like effects of p-fluoroamphetamine in the rat. European Journal of Pharmacology. 287(2). 105–113. 45 indexed citations
15.
Nash, J. Frank, Bryan L. Roth, Jesse Brodkin, David E. Nichols, & Gary A. Gudelsky. (1994). Effect of the R(−) and S(+) isomers of MDA and MDMA on phosphotidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. Neuroscience Letters. 177(1-2). 111–115. 64 indexed citations
16.
Witkin, Jeffrey M., David E. Nichols, Philip Terry, & Jonathan L. Katz. (1991). Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.. Journal of Pharmacology and Experimental Therapeutics. 257(2). 706–713. 165 indexed citations
17.
Johnson, Michael P. & David E. Nichols. (1991). Combined administration of a non-neurotoxic 3,4-methylenedioxymethamphetamine analogue with amphetamine produces serotonin neurotoxicity in rats. Neuropharmacology. 30(7). 819–822. 22 indexed citations
18.
Nichols, David E. & Robert Oberlender. (1989). Structure-Activity Relationships of MDMA-Like Substances. PsycEXTRA Dataset. 94. 1–29. 39 indexed citations
19.
Johnson, Michael P., Andrew J. Hoffman, & David E. Nichols. (1986). Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. European Journal of Pharmacology. 132(2-3). 269–276. 234 indexed citations
20.
Nichols, David E., Andrew J. Hoffman, Robert Oberlender, Peyton Jacob, & Alexander T. Shulgin. (1986). Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class. Journal of Medicinal Chemistry. 29(10). 2009–2015. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard A. Glennon Breakdown of academic impact, for papers by Matthias E. Liechti Breakdown of academic impact, for papers by Richard B. Rothman Breakdown of academic impact, for papers by Franz X. Vollenweider Breakdown of academic impact, for papers by Kenner C. Rice Breakdown of academic impact, for papers by Marius C. Hoener Breakdown of academic impact, for papers by Jordi Riba Breakdown of academic impact, for papers by Adam L. Halberstadt Breakdown of academic impact, for papers by David Erritzøe Breakdown of academic impact, for papers by Glen B. Baker
Rankless by CCL
2026